We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+0.26%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$30.7B
AUM Growth
+$988M
Cap. Flow
+$1.01B
Cap. Flow %
3.28%
Top 10 Hldgs %
54.65%
Holding
2,179
New
164
Increased
802
Reduced
752
Closed
188

Sector Composition

Rank Sector Weight
1 Financials 4.77%
2 Technology 4.11%
3 Healthcare 1.86%
4 Consumer Discretionary 1.76%
5 Industrials 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSTA icon
1476
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.4B
$249K ﹤0.01%
+6,809
New +$245K
FANG icon
1477
Diamondback Energy
FANG
$57.6B
$248K ﹤0.01%
2,759
-624
-18% -$62K
FIEE
1478
DELISTED
FI Enhanced Europe 50 ETN
FIEE
$248K ﹤0.01%
1,543
-189
-11% -$29.8K
LMNX
1479
DELISTED
Luminex Corp
LMNX
$248K ﹤0.01%
12,006
RDY icon
1480
Dr. Reddy's Laboratories
RDY
$9.82B
$247K ﹤0.01%
32,655
+1,020
+3% +$7.59K
YTRA icon
1481
Yatra Online
YTRA
$54.7M
$247K ﹤0.01%
60,000
-173
-0.3% -$716
CAPL icon
1482
CrossAmerica Partners
CAPL
$830M
$246K ﹤0.01%
14,399
+19
+0.1% +$321
IMO icon
1483
Imperial Oil
IMO
$62.1B
$246K ﹤0.01%
9,442
+1,187
+14% +$31.3K
UBNK
1484
DELISTED
United Financial Bancorp, Inc.
UBNK
$246K ﹤0.01%
18,067
PBD icon
1485
Invesco Global Clean Energy ETF
PBD
$186M
$245K ﹤0.01%
20,150
+2,651
+15% +$32.8K
MRTX
1486
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$245K ﹤0.01%
3,150
BIO icon
1487
Bio-Rad Laboratories Class A
BIO
$8.42B
$244K ﹤0.01%
732
+21
+3% +$6.85K
VONV icon
1488
Vanguard Russell 1000 Value ETF
VONV
$20.4B
$244K ﹤0.01%
+4,342
New +$242K
NQP
1489
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$243K ﹤0.01%
17,370
+500
+3% +$7K
OXSQ icon
1490
Oxford Square Capital
OXSQ
$151M
$242K ﹤0.01%
38,900
IVZ icon
1491
Invesco
IVZ
$13.3B
$241K ﹤0.01%
14,223
-3,598
-20% -$63.5K
TER icon
1492
Teradyne
TER
$54.8B
$241K ﹤0.01%
4,167
-29
-0.7% -$1.53K
XHB icon
1493
State Street SPDR S&P Homebuilders ETF
XHB
$1.74B
$241K ﹤0.01%
5,464
+447
+9% +$18.8K
KXI icon
1494
iShares Global Consumer Staples ETF
KXI
$1.03B
$239K ﹤0.01%
+4,356
New +$235K
RHI icon
1495
Robert Half
RHI
$3.61B
$239K ﹤0.01%
4,289
-39
-0.9% -$2.2K
AOD
1496
abrdn Total Dynamic Dividend Fund
AOD
$1.1B
$238K ﹤0.01%
28,506
+11,449
+67% +$94.4K
PPLT
1497
abrdn Physical Platinum Shares ETF
PPLT
$1.81B
$238K ﹤0.01%
28,500
+750
+3% +$6.24K
ARI
1498
Apollo Commercial Real Estate
ARI
$887M
$237K ﹤0.01%
+12,367
New +$233K
GAIA icon
1499
Gaia
GAIA
$47.3M
$237K ﹤0.01%
36,190
UPRO icon
1500
ProShares UltraPro S&P 500
UPRO
$5.1B
$237K ﹤0.01%
8,570
-4,874
-36% -$133K

Similar funds

Creative Planning's Q3 2019 Portfolio in Review

As of Q3 2019, Creative Planning held 2,179 positions worth $30.7B, up 3.3% from $29.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Creative Planning deployed $1.01B of net new capital in Q3 2019, opening 164 new positions and adding to 802 existing holdings. Its largest new stake was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.

By sector, the portfolio is most concentrated in Financials at 4.8% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $92.7M trimmed.

  • Creative Planning's largest Q3 2019 buy was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q3 2019, an estimated $124M increase.
  • Creative Planning's biggest Q3 2019 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $92.7M.
  • Creative Planning fully exited Total System Services, Inc. in Q3 2019, selling an estimated $49.4M.
  • Creative Planning's ten largest holdings make up 55% of its $30.7B portfolio in Q3 2019.
  • Creative Planning opened 164 new positions and closed 188 in Q3 2019.
  • Creative Planning's portfolio value rose 3.3% quarter-over-quarter to $30.7B.

Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.